DCF — PALMER LUTHERAN HEALTH CENTER
Enterprise Value: $-39.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-39.8M
Enterprise Value
$-13.0M
PV of Cash Flows
$-26.9M
PV of Terminal Value
$-43.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $35.5M | $-2.3M | -6.0% | $-3.8M | $-3.4M |
| Year 2 | $36.5M | $-2.0M | -5.0% | $-3.5M | $-2.9M |
| Year 3 | $37.6M | $-1.7M | -4.0% | $-3.3M | $-2.5M |
| Year 4 | $38.8M | $-1.5M | -4.0% | $-3.2M | $-2.2M |
| Year 5 | $39.9M | $-1.5M | -4.0% | $-3.2M | $-2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-39.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$34.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06952017762519093
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5